168 related articles for article (PubMed ID: 3759529)
1. Medulloblastoma: the Duke University Medical Center experience.
Hershatter BW; Halperin EC; Cox EB
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1771-7. PubMed ID: 3759529
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
3. Low-dose craniospinal radiation therapy for medulloblastoma.
Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
[TBL] [Abstract][Full Text] [Related]
5. Treatment results for 149 medulloblastoma patients from one institution.
Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.
Merchant TE; Wang MH; Haida T; Lindsley KL; Finlay J; Dunkel IJ; Rosenblum MK; Leibel SA
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):29-35. PubMed ID: 8823256
[TBL] [Abstract][Full Text] [Related]
7. Protracted radiotherapy treatment duration in medulloblastoma.
Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
[TBL] [Abstract][Full Text] [Related]
8. [Results of radiation therapy for medulloblastoma].
Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?
Belza MG; Donaldson SS; Steinberg GK; Cox RS; Cogen PH
J Neurosurg; 1991 Oct; 75(4):575-82. PubMed ID: 1885975
[TBL] [Abstract][Full Text] [Related]
10. The change in patterns of relapse in medulloblastoma.
Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
[TBL] [Abstract][Full Text] [Related]
11. Pediatric medulloblastoma: radiation treatment technique and patterns of failure.
Miralbell R; Bleher A; Huguenin P; Ries G; Kann R; Mirimanoff RO; Notter M; Nouet P; Bieri S; Thum P; Toussi H
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):523-9. PubMed ID: 9112448
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of medulloblastoma].
Wendt TG; Rohloff R; Bacherler B; Willich N; Lanksch W
Strahlenther Onkol; 1987 Jan; 163(1):1-5. PubMed ID: 3810472
[TBL] [Abstract][Full Text] [Related]
14. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
[TBL] [Abstract][Full Text] [Related]
15. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of a pilot study of low dose cranial-spinal irradiation for cerebellar medulloblastoma.
Brand WN; Schneider PA; Tokars RP
Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1641-5. PubMed ID: 3667370
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.
Sun LM; Yeh SA; Wang CJ; Huang EY; Chen HC; Hsu HC; Lee SP
J Neurooncol; 2002 May; 58(1):77-85. PubMed ID: 12160144
[TBL] [Abstract][Full Text] [Related]
18. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
19. Results of radiosurgery in the management of recurrent and residual medulloblastoma.
Patrice SJ; Tarbell NJ; Goumnerova LC; Shrieve DC; Black PM; Loeffler JS
Pediatr Neurosurg; 1995; 22(4):197-203. PubMed ID: 7619720
[TBL] [Abstract][Full Text] [Related]
20. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
